References
Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004;239:818.
Kawaguchi Y, Lillemoe HA, Panettieri E, et al. Conditional recurrence-free survival after resection of colorectal liver metastases: persistent deleterious association with RAS and TP53 co-mutation. J Am Coll Surg. 2019;229(286–94):e281.
Fromer MW, Scoggins CR, Egger ME, Philips P, McMasters KM, Martin Ii RCG. Preventing futile liver resection: a risk-based approach to surgical selection in major hepatectomy for colorectal cancer. Ann Surg Oncol. 2022;29:905–12. https://doi.org/10.1245/s10434-021-10761-0.
Boyev A, Tzeng C-W, Maki H, et al. Local therapy improves survival for early recurrence after resection of colorectal liver metastases. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-14806-4.
Funding
This research has not received external support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
There are no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article refers to Boyev A, Tzeng C-W, Maki H, et al. Local therapy improves survival for early recurrence after resection of colorectal liver metastases. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-14806-4.
Rights and permissions
About this article
Cite this article
Boyev, A., Newhook, T.E. ASO Author Reflections: Patients with Recurrence Amenable to Local Therapy for Colorectal Liver Metastases May Experience Improved Survival. Ann Surg Oncol 31, 2600–2601 (2024). https://doi.org/10.1245/s10434-024-15005-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-024-15005-5